发明名称 |
composto, formulação farmacêutica, uso de um composto, e, método para o tratamento ou prevenção das condições ou doenças que são prevenidas, tratadas, ou melhoradas pela ação seletiva por intermédio do receptor de leptina0. |
摘要 |
The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias. |
申请公布号 |
BRPI0913448(A2) |
申请公布日期 |
2015.12.01 |
申请号 |
BR2009PI13448 |
申请日期 |
2009.06.04 |
申请人 |
ASTRAZENECA AB |
发明人 |
ANNE VIET-ANH HORGAN;CHARLES TYZACK;IAIN SIMPSON;JAMES HORTON;MICHAEL HIGGINBOTTOM |
分类号 |
A61K31/44;A61K31/4409;A61K31/443;A61K31/4439;A61P3/00;C07D213/30;C07D405/12;C07D413/12 |
主分类号 |
A61K31/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|